— Know what they know.
Not Investment Advice

PYXS Short Interest

Pyxis Oncology, Inc.
1W: +0.0% 1M: -36.5% 3M: -37.0% YTD: +60.0% 1Y: -46.8% 3Y: +12.2% 5Y: -84.0%
$1.84
+0.15 (+8.88%)
Pre-Market: $1.74 (-0.10, -5.43%)
Weekly Expected Move ±12.8%
$1 $1 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 33 · $116.6M mcap · 37M float · 3.45% daily turnover · Short 53% of daily vol
Credit Risk of going bust: higher than 80% of companies Debt: 13.3% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down 99.2%), Pyxis Oncology, Inc. would be worth roughly what it owes.
Total debt $17.8M against a stock market value of $116.6M.
Distance to default 2.56 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.8M (short-term plus half of long-term), stock volatility 133.2%; Altman Z'' -38.53. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Short Volume Summary

2026-10-26
56.8%
Short Ratio
of total volume
53.8%
20-Day Avg
53.8%
50-Day Avg
▲ Rising
5-Day Trend
0.2M
Short Volume
0.3M
Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-26
ExchangeShort VolumeTotal VolumeShort %
NASDAQ 141,983 264,142 53.8%
NYSE 10,836 15,699 69.0%
BATS 14,365 14,365 100.0%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms